PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Crescendo widens pivotal solid tumour therapy trial

The CB307 study expansion involves the addition of a new pembrolizumab combination cohort. Crescendo Biologics, a company focused on T cell-enhancing therapies, h...
Continue Reading →
News

EMA positive opinion for ViiV’s cabotegravir

The drug is an injectable or tablet specifically developed for HIV prevention among certain individuals. ViiV Healthcare – a company focusing on HIV treatments – ...
Continue Reading →
News

Janssen’s Talvey receives positive CHMP opinion

The treatment is a monotherapy for treating adult patients with refractory or relapsed multiple myeloma. The Janssen Pharmaceutical Companies of Johnson & Joh...
Continue Reading →
News

Teva UK launches GoResp Digihaler

The inhaler supports appropriate individuals presenting with asthma and chronic obstructive pulmonary disease. Teva UK has launched GoResp Digihaler across the UK...
Continue Reading →
News

Grifols announces phase 3 progress for Albutein

Therapy has the potential to decrease mortality rates in patients with decompensated cirrhosis. Grifols – a company concentrating on plasma-derived treatments – h...
Continue Reading →
News

TauRx’s deliver Alzheimer’s disease therapy results

The company’s hydromethylthionine mesylate therapy reduced neurodegeneration during the pivotal trial. TauRx Pharmaceuticals – a company focused on Alzheimer’s di...
Continue Reading →
News

Cannabinoid company expands into oncology

OCTP develops cannabinoid medicines and is looking at the potential treatment of cancer malignancies. Oxford Cannabinoid Technologies Holdings (OCTP) – the compan...
Continue Reading →
News

Positive data for Caribou Biosciences’ CB-010 candidate

CAR-T cell therapy is being researched among patients with relapsed or refractory B cell non-Hodgkin lymphoma. Caribou Biosciences – a company focused on genome e...
Continue Reading →
News

Cumulus Neuroscience in partnership with the Universities of Bath and Bristol

The collaboration will focus on progressing tests for the early detection of Alzheimer’s dementia. Cumulus Neuroscience – a company concentrating on neuroscience ...
Continue Reading →
News

Calliditas reveals pivotal setanaxib data

Results are from the company’s phase 2 head and neck cancer trial with lead NOX inhibitor candidate. Calliditas Therapeutics has announced interim data from its p...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026